Brain cancer is one of the eight most common cancers occurring in people aged 40+ and is the fifthleading cause of cancer-related deaths for males aged 40–59. Accurate subtype identification is crucial for precise therapeutic treatment, which largely depends on understanding the biological pathways and regulatory mechanisms associated with different brain cancer subtypes. |